SURFACE ONCOLOGY
Surface Oncology was created to advance next-generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of cancer immuno-biology. Together with world-leading scientific founders, the Company is advancing multiple preclinical programs that target novel mechanisms shown to play vital roles in tumor immune evasion.
SURFACE ONCOLOGY
Industry:
Biotechnology Health Care Life Science Oncology
Founded:
2014-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.surfaceoncology.com
Total Employee:
51+
Status:
Active
Contact:
(617) 714-4096
Total Funding:
88.9 M USD
Technology used in webpage:
Domain Not Resolving IPv6 COVID-19 Akamai Hosted
Similar Organizations
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Boston Oncology
Boston Oncology is a healthcare of citizens in emerging markets around the world through regional development and production of licensed
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Earli
Earli is a developer of cancer treatment devices designed to search for natural biomarkers.
Garuda Therapeutics
Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat severe and life-threatening diseases.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Immunitas Therapeutics
Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Board_member
2021-03-01
Board_member
2018-03-01
Board_member
Board_member
2018-01-01
Board_member
Board_member
Board_member
Current Employees Featured
Wendy Dwyer Chief Business Officer @ Surface Oncology
Chief Business Officer
Geoffrey McDonough Independent Director @ Surface Oncology
Independent Director
2018-04-01
Ben Montgomery Senior Director, Corporate Counsel @ Surface Oncology
Senior Director, Corporate Counsel
2019-11-01
John Ruesch VP Pharmaceutical Development @ Surface Oncology
VP Pharmaceutical Development
2021-12-01
Michael Gladstone Director of Business Operations @ Surface Oncology
Director of Business Operations
Jessica Fees Senior Vice President, Finance @ Surface Oncology
Senior Vice President, Finance
Robert Steininger SVP, CMC and Quality @ Surface Oncology
SVP, CMC and Quality
2018-04-01
Stock Details
Investors List
RS Investments
RS Investments investment in Post-IPO Equity - Surface Oncology
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Surface Oncology
Biotechnology Value Fund
Biotechnology Value Fund investment in Post-IPO Equity - Surface Oncology
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - Surface Oncology
K2 HealthVentures
K2 HealthVentures investment in Debt Financing - Surface Oncology
New Enterprise Associates
New Enterprise Associates investment in Series A - Surface Oncology
Lilly Ventures
Lilly Ventures investment in Series A - Surface Oncology
Amgen Ventures
Amgen Ventures investment in Series A - Surface Oncology
Novartis Institutes for Biomedical Research
Novartis Institutes for Biomedical Research investment in Series A - Surface Oncology
Atlas Venture
Atlas Venture investment in Series A - Surface Oncology
Official Site Inspections
http://www.surfaceoncology.com Semrush global rank: 11.97 M Semrush visits lastest month: 138
- Host name: 103.223.211.130.bc.googleusercontent.com
- IP address: 130.211.223.103
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Surface Oncology"
Surface Oncology - Crunchbase Company Profile
Surface Oncology develops next-generation cancer immunotherapy treatments based on proprietary discoveries.See details»
Surface Oncology Company Profile 2024: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for Surface Oncology. Use the PitchBook Platform to explore the full profile.See details»
Surface Oncology Inc. - LinkedIn
Surface Oncology is a clinical-stage immuno-oncology company focused on using its specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment (TME ...See details»
Surface Oncology Inc. Management Team | Org Chart - RocketReach
Associate Research Project Manager at Surface Oncology Inc. Boston, MA, US View 2 yahoo.com surfaceoncology.com 1 518248XXXXSee details»
Surface Oncology Inc.: Contact Details and Business Profile
Surface Oncology Inc. is a Biotechnology Research, Pharmaceuticals, and Biotechnology company_reader located in Cambridge, Massachusetts with $31.1 million in revenue and 64 …See details»
Surface Oncology Company Profile | Management and Employees …
Find contact information for Surface Oncology. Learn about their Pharmaceuticals, Manufacturing market share, competitors, and Surface Oncology's email format.See details»
Surface Oncology Inc. Overview | SignalHire Company Profile
Surface Oncology Inc. is a public company that has been in the industry for 10 years. The company currently specializes in the Biotechnology, Biotechnology, Pharmaceuticals areasSee details»
Surface Oncology - Overview, News & Similar companies
Jun 17, 2023 View Surface Oncology (www.surfaceoncology.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well …See details»
Surface Oncology Inc. Company Overview, Contact Details
Learn more about Surface Oncology Inc.'s company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
Surface Oncology Inc. Company Profile: , Investments, Contact ...
Surface Oncology is a clinical-stage immuno-oncology company focused on using its specialized knowledge of the biological pathways critical to the immunosuppressive tumor …See details»
Surface Oncology - Org Chart, Teams, Culture & Jobs | The Org
View Surface Oncology's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Surface Oncology - VentureRadar
"Surface Oncology® is developing multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust immunologic …See details»
Surface Oncology - Company Profile - Tracxn
Nov 30, 2024 Surface Oncology - Developer of immunotherapies for the treatment of cancer. Raised a total funding of $35M over 4 rounds from 9 investors.See details»
Company Surface Oncology, Inc. - MarketScreener.com
Surface Oncology, Inc. is a clinical-stage, immuno-oncology company, which is focused on developing immunotherapies that target the tumor microenvironment. The Company is …See details»
Surface Oncology - Craft
Sep 12, 2023 Surface Oncology has 5 employees at their 1 location and $30 m in annual revenue in FY 2022. See insights on Surface Oncology including office locations, competitors, …See details»
About SURFACE ONCOLOGY | DxMultiomics
Surface Oncology is an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment. Its pipeline includes two wholly-owned …See details»
Working at Surface Oncology - Zippia
2014 Website www.surfaceoncology.com Organization Type Public Social Media Surface Oncology was created to advance next-generation approaches to cancer immunotherapy …See details»
Surface Oncology to Appoint Robert Ross, M.D., as President and …
Feb 11, 2021 For more information, please visit www.surfaceoncology.com. Cautionary Note Regarding Forward-Looking Statements:Certain statements set forth in this press release …See details»
Surface Oncology Reports Financial Results and Corporate …
May 4, 2023 Updated clinical data from Phase 2 studies evaluating SRF388 in both liver and lung cancer expected in the second quarter of 2023 Projected cash runway guidance remains …See details»
Surface Oncology (USA) Funding: $88.9M - medicalstartups.org
Surface Oncology is developing next generation immunotherapies that target the immune-suppressive tumor microenvironment to attack...See details»